Related Experiment Video
Updated: Jul 18, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE
L Gargiulo1,2, L Ibba1,2, P Malagoli3
1Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
Abstract
No abstract available in PubMed .

